Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DELIVERABLE VOLUME
Deliverable Volume      
Medicamen Biotech Ltd.
BSE Code 531146
ISIN Demat INE646B01010
Book Value 197.62
NSE Code MEDICAMEQ
Dividend Yield % 0.40
Market Cap 3363.58
P/E 38.02
EPS 6.52
Face Value 10  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
28-Apr-2026 194 138 71.13
27-Apr-2026 1687 1364 80.85
24-Apr-2026 1294 1201 92.81
23-Apr-2026 1186 1169 98.57
22-Apr-2026 940 815 86.70
21-Apr-2026 705 591 83.83
20-Apr-2026 6938 5044 72.70
17-Apr-2026 790 574 72.66
16-Apr-2026 2748 1159 42.18
15-Apr-2026 1139 847 74.36
13-Apr-2026 596 480 80.54
10-Apr-2026 1618 1243 76.82
09-Apr-2026 2459 2325 94.55
08-Apr-2026 2249 1253 55.71
07-Apr-2026 2995 2301 76.83
06-Apr-2026 1629 1204 73.91
02-Apr-2026 2384 1570 65.86
01-Apr-2026 6613 4841 73.20
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.